Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 28.64 |
| PEG Ratio (TTM) | N/A | 5.07 |
| P/S Ratio (TTM) | N/A | 90.17 |
| P/B Ratio (TTM) | 0.55 | 72.96 |
| P/FCF Ratio (TTM) | 13.99 | 65.34 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.68 |
| Price to 5YR AVG FCF Ratio | -107.59 | 51.94 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 4.57% |
| ROE (TTM) | N/A | 8.85% |
| Net Profit Margin (TTM) | N/A | -11.24% |
| ROIC 5YR AVG | 6.91% | 17.21% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.10% | 52.40% | 38.46% |
| Revenue | 163.09% | 75.01% | 42.61% |
| Net Income | 50.59% | 76.62% | 52.14% |
| Cash Flow | 131.30% | -278.80% | 604.56% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.23 | 5.93 |
| Quick Ratio (TTM) | 0.23 | 5.78 |
| D/E Ratio (TTM) | N/A | 0.69 |
| Interest Coverage (TTM) | N/A | 17.71 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 34.98 | 6.32 |
| LTL to 5YR AVG FCF | N/A | 2.41 |
| Shares Outstanding Growth 5YR AVG | 10.06% | 12.89% |